USA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse cardiovascular events (MACE) among patients with rheumatoid ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

However, for the rest of us who don't have these diseases and don’t want to get them, how can we lower our cholesterol ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to assess the benefit of universal blood lipid screening for the early ...

Clinicians are advised to determine which of their patients’ chronic medications are really needed to improve outcomes.

Dutch clinical-stage biotech NewAmsterdam Pharma, which is focused on non-statin medicines for patients at risk of ...

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans fats to promote atherosclerotic cardiovascular disease (ASCVD), explaining ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to assess the benefit of ...

During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...

What are non-pharmaceutical ways to lower my cholesterol? " According to the NHS ... a result comparable to the impact of older statin drugs from the '90s. Breakthrough cancer treatment plan 'could be ...

In patients who have coronary artery disease, peripheral artery disease or carotid artery disease, there is no question about the benefit of cholesterol-lowering medications such as statins.